Lois M Ramondetta Selected Research

Lois M Ramondetta Research Topics

Disease

30	Neoplasms (Cancer) 01/2022 - 09/2003
15	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2022 - 06/2005
15	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 09/2002
7	Carcinoma (Carcinomatosis) 01/2019 - 10/2004
7	Ovarian Neoplasms (Ovarian Cancer) 06/2017 - 04/2006
3	Disease Progression 10/2017 - 02/2014
3	Chronic Disease (Chronic Diseases) 01/2017 - 07/2015
3	Neoplasm Metastasis (Metastasis) 10/2015 - 03/2004
3	Neutropenia 12/2012 - 05/2005
2	Nausea 01/2021 - 12/2010
2	Hyperplasia 01/2021 - 05/2005
2	Ovarian Epithelial Carcinoma 01/2019 - 10/2015
2	Fistula 10/2017 - 02/2014
2	Wounds and Injuries (Trauma) 10/2017 - 11/2003
2	Leiomyosarcoma 12/2016 - 06/2005
2	Adenocarcinoma 06/2013 - 09/2002
2	Anemia 12/2010 - 05/2005
2	Endometrial Stromal Sarcoma 05/2009 - 06/2005
2	Endometrial Hyperplasia 05/2005 - 09/2002
1	Vomiting 01/2021
1	Granulosa Cell Tumor 01/2021
1	Vaginal Neoplasms (Cancer, Vaginal) 01/2021
1	Carcinosarcoma 01/2018
1	Hemorrhage 10/2017
1	Thromboembolism 10/2017
1	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 01/2017
1	Fallopian Tube Neoplasms 10/2015
1	Anaphylaxis (Anaphylactic Shock) 07/2015
1	Ovarian Diseases (Ovarian Disease) 01/2015
1	Body Weight (Weight, Body) 02/2014
1	Hypertension (High Blood Pressure) 02/2014
1	Obesity 04/2011
1	Insulin Resistance 04/2011
1	Fatigue 12/2010
1	Lymphopenia (Lymphocytopenia) 12/2010

Drug/Important Bio-Agent (IBA)

11	Cisplatin (Platino)FDA LinkGeneric 10/2017 - 09/2003
6	PlatinumIBA 04/2022 - 01/2004
5	Bevacizumab (Avastin)FDA Link 04/2022 - 02/2014
5	Adrenergic Agents (Adrenergic Drugs)IBA 07/2020 - 01/2013
4	Pharmaceutical PreparationsIBA 11/2020 - 12/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2017 - 02/2014
3	Topotecan (Hycamtin)FDA LinkGeneric 10/2017 - 02/2014
3	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2017 - 07/2015
3	Gemcitabine FDA Link 11/2010 - 01/2004
2	AntigensIBA 01/2022 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2017
2	pembrolizumabIBA 01/2021 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 02/2014
2	VaccinesIBA 05/2020 - 01/2015
2	amsonic acid (DAS)IBA 08/2015 - 07/2015
2	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2013 - 01/2013
2	Estrogens (Estrogen)FDA Link 04/2011 - 05/2005
2	Mifepristone (RU 486)FDA Link 05/2009 - 08/2008
2	Progesterone Receptors (Progesterone Receptor)IBA 05/2009 - 05/2005
2	Gefitinib (Iressa)FDA Link 03/2009 - 06/2008
2	Antineoplastic Agents (Antineoplastics)IBA 03/2009 - 06/2008
2	Phosphotransferases (Kinase)IBA 06/2005 - 10/2004
2	Imatinib Mesylate (Gleevec)FDA Link 06/2005 - 10/2004
2	Tyrosine (L-Tyrosine)FDA Link 06/2005 - 10/2004
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Levonorgestrel (Plan B)FDA LinkGeneric 01/2021
1	Ondansetron (Zofran)FDA LinkGeneric 01/2021
1	lenvatinibIBA 01/2021
1	Granisetron (Kytril)FDA LinkGeneric 01/2021
1	AntiemeticsIBA 01/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2020
1	Hormones (Hormone)IBA 07/2020
1	Papillomavirus Vaccines (HPV Vaccines)IBA 05/2020
1	Propranolol (Inderal)FDA LinkGeneric 01/2019
1	CreatinineIBA 10/2017
1	env Gene ProductsIBA 01/2015
1	AntibodiesIBA 01/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2015
1	Pemetrexed (MTA)FDA Link 09/2014
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2013
1	Cyclic AMP (AMP, Cyclic)IBA 01/2013
1	Albumin-Bound Paclitaxel FDA Link 12/2012
1	Drug CombinationsIBA 12/2012
1	130-nm albumin-bound paclitaxelIBA 12/2012
1	acivicin (AT 125)IBA 12/2012
1	Glucose (Dextrose)FDA LinkGeneric 04/2011
1	Insulin (Novolin)FDA Link 04/2011
1	Hematoxylin (Haematoxylon)IBA 12/2010
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2010

Therapy/Procedure

19	Therapeutics 01/2021 - 05/2005
17	Drug Therapy (Chemotherapy) 04/2022 - 03/2004
6	Radiotherapy 01/2018 - 03/2004
5	Lymph Node Excision (Lymph Node Dissection) 10/2021 - 11/2010
5	Hysterectomy 10/2021 - 03/2004
3	Adjuvant Chemotherapy 05/2013 - 03/2004
2	Chemoradiotherapy 01/2022 - 01/2008
2	Terminal Care (Care, Terminal) 06/2017 - 10/2014
2	Palliative Care (Palliative Therapy) 01/2017 - 12/2015
2	Combination Drug Therapy (Combination Chemotherapy) 02/2014 - 11/2010
1	Complementary Therapies (Alternative Medicine) 01/2021
1	Intrauterine Devices (Intrauterine Device) 01/2021
1	Ambulatory Care (Outpatient Care) 01/2017
1	Hospice Care (Care, Bereavement) 11/2014
1	Pelvic Exenteration 09/2014
1	Drug Tapering 12/2012